tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Instil Bio Reports Promising Phase 2 Study Results
PremiumCompany AnnouncementsInstil Bio Reports Promising Phase 2 Study Results
3M ago
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
Premium
The Fly
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
3M ago
Instil Bio announces FDA clearance of IND application for AXN-2510
Premium
The Fly
Instil Bio announces FDA clearance of IND application for AXN-2510
4M ago
Instil Bio Advances Phase 2 Trial in China
PremiumCompany AnnouncementsInstil Bio Advances Phase 2 Trial in China
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Instil Bio’s Phase 2 trial of asset AXN-2510 to complete enrollment in China
PremiumThe FlyInstil Bio’s Phase 2 trial of asset AXN-2510 to complete enrollment in China
5M ago
Instil Bio reports Q1 EPS ($1.32) vs ($2.39) last year
Premium
The Fly
Instil Bio reports Q1 EPS ($1.32) vs ($2.39) last year
5M ago
Instil Bio’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
Premium
Ratings
Instil Bio’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100